Liver transplantation in a patient with hereditary haemorrhagic telangiectasia and pulmonary hypertension.
Rendu-Osler-Weber syndrome
arteriovenous malformation
pulmonary haemorrhage
Journal
Pulmonary circulation
ISSN: 2045-8932
Titre abrégé: Pulm Circ
Pays: United States
ID NLM: 101557243
Informations de publication
Date de publication:
Historique:
received:
06
08
2019
accepted:
03
12
2019
entrez:
7
1
2020
pubmed:
7
1
2020
medline:
7
1
2020
Statut:
epublish
Résumé
Hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber syndrome is a systemic vascular disease with autosomal dominant inheritance, mucocutaneous telangiectasia, and repeated nasal bleeding due to vascular abnormalities. Hereditary haemorrhagic telangiectasia may occasionally lead to complications, including arteriovenous malformations and pulmonary hypertension. We present a case of a 52-year-old female patient with hereditary haemorrhagic telangiectasia who was referred to our hospital for treatment of pulmonary hypertension. She had been diagnosed with hereditary haemorrhagic telangiectasia during adolescence and was being followed up. Six months prior to presentation, she had undergone coil embolization for pulmonary haemorrhage due to pulmonary arteriovenous malformations. She was in World Health Organization functional class IV, with a mean of pulmonary arterial pressure of 38 mmHg, a pulmonary capillary wedge pressure of 10 mmHg, and a right atrial pressure of 22 mmHg. A contrast-enhanced computed tomography angiography showed large arteriovenous malformations in the liver. Right heart catheterization revealed an increase in oxygen saturation in the inferior vena cava between the supra- and infra-hepatic veins, low pulmonary vascular resistance, and high right atrial pressure. Hence, she was diagnosed with hereditary haemorrhagic telangiectasia with pulmonary hypertension due to major arteriovenous shunt resulting from arteriovenous malformations in the liver. Therefore, we considered liver transplantation as an essential treatment option. She underwent cadaveric liver transplantation after a year resulting in dramatic haemodynamic improvement to World Health Organization functional class I. Liver transplantation is a promising treatment in patients with hereditary haemorrhagic telangiectasia and pulmonary hypertension resulting from arteriovenous shunt caused by arteriovenous malformations in the liver.
Identifiants
pubmed: 31903186
doi: 10.1177/2045894019896677
pii: 10.1177_2045894019896677
pmc: PMC6923528
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2045894019896677Informations de copyright
© The Author(s) 2019.
Références
Ann Surg. 2006 Dec;244(6):854-62; discussion 862-4
pubmed: 17122610
Liver Transpl. 2000 Jul;6(4):443-50
pubmed: 10915166
N Engl J Med. 2000 Sep 28;343(13):931-6
pubmed: 11006369
N Engl J Med. 1995 Oct 5;333(14):918-24
pubmed: 7666879
Eur Respir J. 2009 May;33(5):1186-94
pubmed: 19407052
JAMA. 2012 Mar 7;307(9):948-55
pubmed: 22396517